University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Anticholinergic drugs and risk of dementia : case-control study

Simple item page
dc.contributor.authorRichardson, Kathryn
dc.contributor.authorFox, Chris
dc.contributor.authorMaidment, Ian
dc.contributor.authorSteel, Nicholas
dc.contributor.authorLoke, Yoon K.
dc.contributor.authorArthur, Antony
dc.contributor.authorMyint, Phyo K
dc.contributor.authorGrossi, Carlota M.
dc.contributor.authorMattishent, Katharina
dc.contributor.authorBennett, Kathleen
dc.contributor.authorCampbell, Noll L.
dc.contributor.authorBoustani, Malaz
dc.contributor.authorRobinson, Louise
dc.contributor.authorBrayne, Carol
dc.contributor.authorMatthews, Fiona E.
dc.contributor.authorSavva, George M.
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2018-04-30T08:48:09Z
dc.date.available2018-04-30T08:48:09Z
dc.date.issued2018-04-25
dc.descriptionWe thank Ms Tarita Murray-Thomas (Medicines and Healthcare products Regulatory Agency) for extracting the CPRD data, Mr Keshav Bajaj (Aston University) for assisting with drugs coding, and Prof Ryan Carnahan for providing the Anticholinergic Drug Scale (ADS). We thank Mr Barry Plumpton, Mrs Ann McLauchlan, Mrs Barbara di Vita, and Mrs Gloria Swan for their assistance and oversight as Alzheimer’s Society Research Network Volunteers. Funding: This research was supported by the Alzheimer’s Society (AS-PG-2013-017). The funders had no role is the design of the study or the interpretation of the findings.en
dc.description.statusPeer revieweden
dc.format.extent12
dc.format.extent300619
dc.identifier119171514
dc.identifier68a5ff01-69d3-4918-b567-73d46a812961
dc.identifier29695481
dc.identifier85045969637
dc.identifier.citationRichardson, K, Fox, C, Maidment, I, Steel, N, Loke, Y K, Arthur, A, Myint, P K, Grossi, C M, Mattishent, K, Bennett, K, Campbell, N L, Boustani, M, Robinson, L, Brayne, C, Matthews, F E & Savva, G M 2018, 'Anticholinergic drugs and risk of dementia : case-control study', BMJ, vol. 361, k1315. https://doi.org/10.1136/bmj.k1315en
dc.identifier.doi10.1136/bmj.k1315
dc.identifier.issn0959-8146
dc.identifier.otherPubMedCentral: PMC5915701
dc.identifier.otherORCID: /0000-0003-3852-6158/work/163199059
dc.identifier.urihttp://hdl.handle.net/2164/10384
dc.identifier.vol361en
dc.language.isoeng
dc.relation.ispartofBMJen
dc.subjectR Medicine (General)en
dc.subjectSupplementary Dataen
dc.subject.lccR1en
dc.titleAnticholinergic drugs and risk of dementia : case-control studyen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
bmj.k1315.full.pdf
Size:
293.57 KB
Format:
Adobe Portable Document Format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.31 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
University Office research